Tevogen Bio Holdings Inc. financial data

Symbol
TVGN, TVGNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
15 Independence Boulevard, Suite 410, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Semper Paratus Acquisition Corp (to 2/15/2024)
Latest financial report
10-K - Q4 2024 - Apr 2, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 27.5 % +744%
Debt-to-equity -155 % -252%
Return On Equity 209 % +190%
Return On Assets -381 % -31.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184M shares +11.7%
Common Stock, Shares, Outstanding 178M shares +48.3%
Entity Public Float 21.4M USD -15.9%
Common Stock, Value, Issued 17.8K USD +48.3%
Weighted Average Number of Shares Outstanding, Basic 147M shares +493%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +493%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 31M USD +605%
General and Administrative Expense 22.5M USD +408%
Costs and Expenses 29.5M USD +884%
Operating Income (Loss) -53.6M USD -506%
Nonoperating Income (Expense) 2.21M USD -58.8%
Net Income (Loss) Attributable to Parent -13.7M USD +77.3%
Earnings Per Share, Basic -0.07 USD/shares +97.1%
Earnings Per Share, Diluted -0.07 USD/shares +97.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 0 USD
Assets, Current 2.36M USD +37%
Property, Plant and Equipment, Net 296K USD -35.4%
Operating Lease, Right-of-Use Asset 228K USD -51.4%
Other Assets, Noncurrent 576K USD +112%
Assets 3.46M USD -37.1%
Accounts Payable, Current 5.2M USD +52.1%
Accrued Liabilities, Current 1.71M USD +56.2%
Liabilities, Current 9.04M USD -89.4%
Operating Lease, Liability, Noncurrent 5.8K USD -97.5%
Liabilities 10.1M USD -89.9%
Retained Earnings (Accumulated Deficit) -113M USD -13.8%
Stockholders' Equity Attributable to Parent -6.67M USD +92.9%
Liabilities and Equity 3.46M USD -37.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.16M USD +0.61%
Net Cash Provided by (Used in) Financing Activities 2.43M USD -2.83%
Net Cash Provided by (Used in) Investing Activities -133K USD
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 178M shares +48.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.28M USD +21.9%
Deferred Tax Assets, Valuation Allowance 16.6M USD +123%
Deferred Tax Assets, Gross 16.6M USD +120%
Operating Lease, Liability 235K USD
Depreciation 40.6K USD +2.06%
Payments to Acquire Property, Plant, and Equipment 133K USD
Lessee, Operating Lease, Liability, to be Paid 244K USD
Property, Plant and Equipment, Gross 722K USD 0%
Operating Lease, Liability, Current 229K USD -9.36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 230K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.59K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.81M USD +81.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares +1900%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 97.9M USD +1776%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 59.7K USD -51.4%
Share-based Payment Arrangement, Expense 3.33M USD
Interest Expense 12.5K USD -95.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%